The AngioSculpt PTA scoring balloon catheter in 7 and 8 millimeter diameter balloon sizes are ideally suited to treat the narrowing of the native or synthetic fistula. The product assists physicians with a difficult patient set, targeting lesions in the hemodialysis access that are resistant to standard balloon angioplasty.
By clicking on the link, you will be leaving the official Royal Philips ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.
По вопросам приобретения оборудования или сервисной поддержки вы можете связаться с нашими официальными дистрибьюторами и сервисными партнерами.
ТОВ "АФС Медицинтехнік"
+38 (044) 359 00 88
+38 (050) 590 50 50
Media Gallery
Features
Precision: Minimal slippage
Precision: Minimal slippage
Rectangular scoring edges lock the device in place. No significant device slippage or “watermelon seeding” means less risk of damage to healthy tissue.⁴,⁵
Precision: Minimal slippage
Rectangular scoring edges lock the device in place. No significant device slippage or “watermelon seeding” means less risk of damage to healthy tissue.⁴,⁵
Precision: Minimal slippage
Rectangular scoring edges lock the device in place. No significant device slippage or “watermelon seeding” means less risk of damage to healthy tissue.⁴,⁵
Rectangular scoring edges lock the device in place. No significant device slippage or “watermelon seeding” means less risk of damage to healthy tissue.⁴,⁵
Power: More dilitation force
Power: More dilitation force
The leading edges are designed to drive outward expansion with up to ~15-25 times the force of a conventional balloon.³
AngioSculpt’s helical nitinol element creates a uniform initial luminal enlargement
Power: More dilitation force
The leading edges are designed to drive outward expansion with up to ~15-25 times the force of a conventional balloon.³
AngioSculpt’s helical nitinol element creates a uniform initial luminal enlargement
Power: More dilitation force
The leading edges are designed to drive outward expansion with up to ~15-25 times the force of a conventional balloon.³
AngioSculpt’s helical nitinol element creates a uniform initial luminal enlargement
The leading edges are designed to drive outward expansion with up to ~15-25 times the force of a conventional balloon.³
AngioSculpt’s helical nitinol element creates a uniform initial luminal enlargement
Safety: Low dissection rate
Safety: Low dissection rate
Post scoring, outward forces are designed to be equivalent to that of a conventional balloon resulting in a low dissection rate and minimal perforations, along with a low rate of adjunctive stenting.⁴,⁵
Safety: Low dissection rate
Post scoring, outward forces are designed to be equivalent to that of a conventional balloon resulting in a low dissection rate and minimal perforations, along with a low rate of adjunctive stenting.⁴,⁵
Safety: Low dissection rate
Post scoring, outward forces are designed to be equivalent to that of a conventional balloon resulting in a low dissection rate and minimal perforations, along with a low rate of adjunctive stenting.⁴,⁵
Post scoring, outward forces are designed to be equivalent to that of a conventional balloon resulting in a low dissection rate and minimal perforations, along with a low rate of adjunctive stenting.⁴,⁵
Resistant stenoses
Resistant stenoses
Lesions resistant to PTA are common and as many as 20% will require a high pressure dilatation (greater than 20 atm)¹
Resistant stenoses
Lesions resistant to PTA are common and as many as 20% will require a high pressure dilatation (greater than 20 atm)¹
Resistant stenoses
Lesions resistant to PTA are common and as many as 20% will require a high pressure dilatation (greater than 20 atm)¹
Recoil
Recoil
Recoil and neointimal proliferation frequently lead to recurrent access dysfunction within several months of the angioplasty procedure²
Recoil
Recoil and neointimal proliferation frequently lead to recurrent access dysfunction within several months of the angioplasty procedure²
Recoil
Recoil and neointimal proliferation frequently lead to recurrent access dysfunction within several months of the angioplasty procedure²
Recurrent stenoses
Recurrent stenoses
~50% of all patients who undergo PTA will return with recurrent stenoses within 6 months⁶
Recurrent stenoses
~50% of all patients who undergo PTA will return with recurrent stenoses within 6 months⁶
Recurrent stenoses
~50% of all patients who undergo PTA will return with recurrent stenoses within 6 months⁶
Rectangular scoring edges lock the device in place. No significant device slippage or “watermelon seeding” means less risk of damage to healthy tissue.⁴,⁵
Precision: Minimal slippage
Rectangular scoring edges lock the device in place. No significant device slippage or “watermelon seeding” means less risk of damage to healthy tissue.⁴,⁵
Precision: Minimal slippage
Rectangular scoring edges lock the device in place. No significant device slippage or “watermelon seeding” means less risk of damage to healthy tissue.⁴,⁵
Rectangular scoring edges lock the device in place. No significant device slippage or “watermelon seeding” means less risk of damage to healthy tissue.⁴,⁵
Power: More dilitation force
Power: More dilitation force
The leading edges are designed to drive outward expansion with up to ~15-25 times the force of a conventional balloon.³
AngioSculpt’s helical nitinol element creates a uniform initial luminal enlargement
Power: More dilitation force
The leading edges are designed to drive outward expansion with up to ~15-25 times the force of a conventional balloon.³
AngioSculpt’s helical nitinol element creates a uniform initial luminal enlargement
Power: More dilitation force
The leading edges are designed to drive outward expansion with up to ~15-25 times the force of a conventional balloon.³
AngioSculpt’s helical nitinol element creates a uniform initial luminal enlargement
The leading edges are designed to drive outward expansion with up to ~15-25 times the force of a conventional balloon.³
AngioSculpt’s helical nitinol element creates a uniform initial luminal enlargement
Safety: Low dissection rate
Safety: Low dissection rate
Post scoring, outward forces are designed to be equivalent to that of a conventional balloon resulting in a low dissection rate and minimal perforations, along with a low rate of adjunctive stenting.⁴,⁵
Safety: Low dissection rate
Post scoring, outward forces are designed to be equivalent to that of a conventional balloon resulting in a low dissection rate and minimal perforations, along with a low rate of adjunctive stenting.⁴,⁵
Safety: Low dissection rate
Post scoring, outward forces are designed to be equivalent to that of a conventional balloon resulting in a low dissection rate and minimal perforations, along with a low rate of adjunctive stenting.⁴,⁵
Post scoring, outward forces are designed to be equivalent to that of a conventional balloon resulting in a low dissection rate and minimal perforations, along with a low rate of adjunctive stenting.⁴,⁵
Resistant stenoses
Resistant stenoses
Lesions resistant to PTA are common and as many as 20% will require a high pressure dilatation (greater than 20 atm)¹
Resistant stenoses
Lesions resistant to PTA are common and as many as 20% will require a high pressure dilatation (greater than 20 atm)¹
Resistant stenoses
Lesions resistant to PTA are common and as many as 20% will require a high pressure dilatation (greater than 20 atm)¹
Recoil
Recoil
Recoil and neointimal proliferation frequently lead to recurrent access dysfunction within several months of the angioplasty procedure²
Recoil
Recoil and neointimal proliferation frequently lead to recurrent access dysfunction within several months of the angioplasty procedure²
Recoil
Recoil and neointimal proliferation frequently lead to recurrent access dysfunction within several months of the angioplasty procedure²
Recurrent stenoses
Recurrent stenoses
~50% of all patients who undergo PTA will return with recurrent stenoses within 6 months⁶
Recurrent stenoses
~50% of all patients who undergo PTA will return with recurrent stenoses within 6 months⁶
Recurrent stenoses
~50% of all patients who undergo PTA will return with recurrent stenoses within 6 months⁶
1. Trerotola, et al. Prospective study of balloon inflation pressures and other technical aspects of hemodialysis access angioplasty. JVIR. 2005 Dec;16(12):1613-8.
2. Dolmatch B. Maintenance of Hemodialysis Access With Stents and Covered Stents. Endovascular Today. June (2010): 55-59.
3. AngioSculpt Test Plan ST-1197 (2008), on file at Philips.
4. Scheinert D, Graziani L, Peeters P, Bosiers M, O’Sullivan G, Sultan S, Gershony G. Results of the Multi-Center First-in-Man Study of a Novel Scoring Balloon Catheter for the Treatment of Infra-Popliteal Peripheral Arterial Disease. Catheterization and Cardiovascular Interventions. 2007;70:1034-1039.
5. Kiesz RS, Scheinert D, Peeters PJ, et al. Results from the international registry of the AngioSculpt Scoring Balloon Catheter for the treatment of infra-popliteal disease. J Am Coll Cardiol. 2008;51:10 (suppl B);75.
6. Fresenius Medical Care 2014 annual report
By clicking on the link, you will be leaving the official Royal Philips ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.
Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.
Ви заходите на сайт Philips Healthcare
Please select the checkbox
Веб-сайт призначений лише для лікарів та медичних працівників, які використовують медичне обладнання в своїй професійній діяльності; осіб, які працюють в сфері організації охорони здоров’я або які реалізовують медичне обладнання.
